Hello, this is Daily Stock, delivering key market insights after the closing bell of the Korean stock market.
[Image: /stdaily/uploads/202606/gen_6a2919cf2ea124.47746491.png]
Key Highlights
Chunbo (278280), a company specializing in fine chemistry and electronic advanced materials, plunged to a 52-week low of KRW 37,250 during trading on June 10, 2026, before ultimately closing at KRW 39,650.
Despite the electronic materials division defending well amid an improving semiconductor industry, the recovery in demand for the electrolyte division—its main business—remains sluggish.
The most significant drag is the KRW 100 billion convertible bond (CB) early redemption claim (put option) risk, which has become a major concern due to the prolonged stock price decline, coupled with worries regarding financing for its subsidiary.
Amid a continuing divergence in supply and demand between large-cap growth stocks and small-to-medium tech advanced materials stocks within the Kosdaq 150 index, we analyze Chunbo's financial status and key risk factors.
Summary of Current Status
Today, the Kosdaq index closed at 951.63, clearly reflecting the overall liquidity contraction and volatility in growth stocks.
According to the Daily Stock Fear & Greed Index, the KOSPI Fear & Greed Index is currently in "Fear" (31.4), and the Nasdaq Fear & Greed Index is also in "Fear" (33.5), indicating a significant contraction in global investment sentiment.
Amid this environment of fear, Chunbo finished trading at KRW 39,650 on June 10, down 0.25% from the previous session, showing heavy movement near its yearly low.
With the stock price significantly below the conversion price, concerns over bondholders potentially exercising early redemption rights are adding to the volatility risks caused by low liquidity gaps.
Financial Analysis
Chunbo's consolidated revenue for the first quarter of 2026 stood at KRW 40.8 billion, a 14.7% increase year-on-year.
The operating loss continued at KRW 3.4 billion, but this was a relatively strong defense, outperforming the market consensus of around a KRW 5 billion loss.
The electronic materials division, which includes fine chemicals and semiconductor materials, served as a pillar for consolidated earnings, maintaining profitability (operating margin of approximately 23%) on the back of recovering IT demand.
However, continuous capital expenditures (CAPEX), including the large-scale expansion of the Saemangeum plant, have led to significant depreciation costs each quarter, acting as a primary financial drag delaying an operating profit turnaround.
| Evaluation Item | FY2025 (Consolidated) | Q1 2026 (Consolidated) | FY2026 Forecast (E) |
|---|---|---|---|
| **Revenue** | KRW 139.0 billion | KRW 40.8 billion | KRW 189.1B ~ 199.4B |
| **Operating Profit** | Turned to Red | KRW -3.4 billion | KRW -11.5B ~ -20.3B |
| **Net Income** | Continued Deficit | KRW -8.5 billion | Deficit expected to continue |
| **BPS (Book Value Per Share)** | KRW 36,443 | KRW 33,161 | Approx. KRW 33,853 ~ 34,055 |
Valuation
Chunbo's price-to-earnings ratio (PER) for 2026 is currently N/A due to the forecasted annual operating loss.
On the other hand, its price-to-book ratio (PBR) has fallen to approximately 1.1x based on the current price of KRW 39,650, clinging to the lower band of its book value per share (BPS), which represents its liquidation value.
EV/EBITDA, which reflects a company's future cash-generating ability, is significantly lower at around 5x to 6x for 2026, excluding the depreciation burden once the Saemangeum plant is fully operational, increasing its long-term value appeal.
As an advanced materials growth stock, Chunbo is passing through a valuation re-rating phase after a period of overvaluation on a price-to-sales ratio (PSR) basis.
Analyst & Institutional View
[Image: /stdaily/uploads/202606/gen_6a2919dc82d060.43258770.png]
Key financial investment experts trust Chunbo's unrivaled technological gap in next-generation F-electrolyte (LiFSI) and precision advanced chemical materials.
However, they agree that the cost innovation benefits from mass production expected by the market are unlikely to manifest in the short term, and the depreciation burden will continue for several quarters.
Accordingly, major institutions such as Samsung Securities have lowered Chunbo's target price to KRW 47,000 while maintaining a "HOLD" rating.
Furthermore, while its subsidiary, Chunbo BLS, recently raised KRW 78.2 billion in facility funds through a private placement of convertible bonds (CBs), the conditional clauses requiring early redemption in the event of an IPO failure are leading institutions to adopt a conservative approach.
Risk Factors
The most immediate short-term negative factor is the potential exercise of put options (early redemption claims) on the KRW 100 billion convertible bonds (CBs) due to the prolonged stock price underperformance.
As the stock price is significantly below the conversion price, bondholders may choose not to convert to equity and instead request immediate principal redemption, raising financial liquidity concerns.
In addition, macro conditions remain unfavorable, with the Federal Reserve's high-for-longer rate stance and the USD/KRW exchange rate rising to the 1,524.80 level, driving up corporate financing costs.
Lastly, if the recovery volume of high-value-added, next-generation electrolyte additives remains sluggish due to the global EV chasm (temporary demand stagnation before mainstream adoption), the risk of being unable to offset fixed overhead costs remains.
Investment Outlook Summary
With Chunbo hitting a 52-week low and correcting more than 85% from its previous peak, some argue that the stock has entered a long-term attractive valuation zone.
However, for the stock to establish a firm bottom at the current closing price of KRW 39,650, the company must first present concrete funding scenarios to address the aforementioned KRW 100 billion CB redemption risk.
Given the slowdown in macro supply-demand dynamics and overall growth stock liquidity, investors may need to adopt a patient, staggered accumulation strategy rather than rushing to buy on the dip.
It is advisable to track and observe the stock, focusing on inflection points where earnings visibility improves and potential debt risks are diluted.
Investment Checklist
* CB Early Redemption Response Capability: Chunbo's cash holdings and additional borrowing capacity during the put option exercise period for the KRW 100 billion CB.
* Depreciation Expense Trend: Whether revenue volume growth is sufficient to offset the quarterly fixed-cost burden following the operation of the Saemangeum plant.
* Growth Rate of Semiconductor/Fine Chemical Division: Whether the revenue proportion of high-value-added display and semiconductor process additives continues to rise to cushion the sluggish rechargeable battery segment.
* Nasdaq and Exchange Rate Trends: Forex exposure as the USD/KRW exchange rate breaches the 1,524.80 level, and the timing of normalization in synchronization with Nasdaq growth stocks.
* BPS Support Level Test: Whether the current stock price strongly holds the historical low BPS support band of KRW 33,000 to KRW 34,000.